Physician

Adel Olshansky, M.D.

According to 2025 Medicare claims, Adel Olshansky, M.D. (NPI: 1063694115) practices neurology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. Olshansky uses personal NPI as billing NPI and primary practice location at 91307-1994.

Olshansky's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 427 traditional Medicare patients, billed 10,068 HCPCS/CPT codes, and received $211,438 in Medicare payments. The top billing code was 95911 (Nerve conduction, 9-10 studies). Part D data shows 3,879 prescription claims across 475 beneficiaries totaling $1,869,578 in drug costs, led by Skyclarys (Omaveloxolone). 2023 DME data shows 12 claims. Open Payments data shows 86 records totaling $1,861. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $207,408 to $1,869,578. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $790 and ending at $1,668.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	452	3,070	$200,820
2016	467	5,380	$211,191
2017	510	4,578	$210,898
2018	395	6,299	$158,201
2019	297	5,774	$128,433
2020	345	6,671	$144,801
2021	367	9,529	$180,656
2022	386	8,617	$191,070
2023	394	9,626	$186,414
2024	427	10,068	$211,438

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	177	1,191	$207,408
2016	207	1,657	$346,489
2017	228	2,166	$693,054
2018	275	2,360	$938,022
2019	301	2,550	$1,133,985
2020	289	2,696	$1,483,224
2021	295	2,990	$1,735,779
2022	360	3,486	$1,616,566
2023	375	3,370	$1,645,941
2024	475	3,879	$1,869,578

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	11	$153
2023	N/R	12	$288
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95911	Nerve conduction, 9-10 studies	38	38	$184
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	174	174	$173
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	304	593	$141
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	53	75	$101
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	58	120	$81

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Skyclarys	Omaveloxolone	11	330	$356,101
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	29	659	$289,093
Privigen	Immun Glob G(Igg)/Pro/Iga 0-50	11	308	$100,306
Botox	Onabotulinumtoxina	59	4,792	$88,971
Panzyga	Immun Glob G(Igg)-Ifas/Glycine	11	330	$88,716

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	86	$1,861	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adel Olshansky, M.D.?

Tedicare shows public-source Medicare data for Adel Olshansky, M.D. (NPI 1063694115), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adel Olshansky, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adel Olshansky, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Adel Olshansky, M.D. have Open Payments data?

Adel Olshansky, M.D. has 86 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.